News
CATALIS’ Management Being Supported by Two New Advisory Committees
CATALIS’ Management Being Supported by Two New Advisory Committees Until recently, CATALIS’ management has been guided by three main advisory committees: a patient advisory committee made up of fifteen patient and patient-partner associations, a scientific and innovation advisory committee made up of expert clinical researchers, and an operations advisory committee made up of senior representatives from health institutions, pharmaceutical
Sanofi Pharmaceutical Company’s First Clinical Trial Approved Through CATALIS Quebec’s FAST TRACK Evaluation Service
Sanofi Pharmaceutical Company’s First Clinical Trial Approved Through CATALIS Quebec’s FAST TRACK Evaluation Service Following Novartis, Boehringer, and Roche, Sanofi is now CATALIS’ fourth pharmaceutical partner to pilot its FAST TRACK Evaluation Service. Sanofi’s Phase I-ll study, which uses human subjects for the first time and is designed to assess the safety and the pharmacokinetic, pharmacodynamic, and antitumor activity
Roche Pharmaceutical Company’s First Clinical Trial Approved Through CATALIS Quebec’s FAST TRACK Evaluation Service
Roche Pharmaceutical Company’s First Clinical Trial Approved Through CATALIS Quebec’s FAST TRACK Evaluation Service Thanks to CATALIS’ FAST TRACK evaluation service, Roche’s ProHer multi-centre study, which explores a new treatment method for patients with breast cancer, was approved in 10 weeks by the CHU de Québec-Université Laval. More specifically, this study seeks to discover patients’ preference for at-home administration
CATALIS Quebec Partners With N2 Canada for Provincial Contract Access to the CITI-Canada Training Platform
CATALIS Quebec Partners With N2 Canada for Provincial Contract Access to the CITI-Canada Training Platform CATALIS Quebec is very proud to partner with N2 Canada to provide its Network member healthcare institutions access to a shared training platform designed to ensure the conduct of high-quality research: the CITI-Canada training platform. Through this partnership, CATALIS Quebec officially becomes the new
Two New Projects Successfully Authorized Within Seven Weeks Thanks to CATALIS QUEBEC’S FAST TRACK Evaluation Service
Two New Projects Successfully Authorized Within Seven Weeks Thanks to CATALIS QUEBEC’S FAST TRACK Evaluation Service While the first-ever FAST TRACK evaluation service pilot project was successfully completed last December, CATALIS is proud to announce that two more clinical trials have now been approved in record time. The second FAST TRACK evaluation service coordinated a Phase I oncology study
Launch of New Shared Clinical Research Tools
Launch of New Shared Clinical Research Tools CATALIS and its network of public and private partners have facilitated the implementation of new shared tools designed to optimize the launching and conducting of clinical trials in Quebec; more specifically, CATALIS has coordinated the revision of documents serving to optimize the contract negotiation process with private industry and a memo which serves to
Danika Laberge Has Been Appointed President and Chief Executive Officer of CATALIS Quebec
Danika Laberge Has Been Appointed President and Chief Executive Officer of CATALIS Quebec CATALIS Quebec’s Board of Directors is pleased to announce the appointment of Danika Laberge as the organization’s President and Chief Executive Officer (CEO). “It is with tremendous enthusiasm and confidence in her abilities that the Board of Directors has appointed Ms. Laberge to the position of
Job Offer : Project Manager
We’re looking for a Project Manager who will help implement and conduct activities related to the FAST TRACK evaluation service for clinical trials in Québec. To view the job offer, click here.
CATALIS Quebec’s Network of Partners Now Includes 23 Quebec Health Institutions
CATALIS Quebec’s Network of Partners Now Includes 23 Quebec Health Institutions In keeping with its new government mandate of bringing together clinical research stakeholders, CATALIS Quebec is pleased to announce that it is expanding the scope of its activities to a larger number of institutions in the province: it has added 23 public institutions from Quebec’s health and social
Two New Administrators Join the CATALIS Board of Directors
Two New Administrators Join the CATALIS Board of Directors Dr. Guy A. Rouleau Dr. Guy Rouleau is Director of The Neuro (Montreal Neurological Institute-Hospital), Chair of the Department of Neurology and Neurosurgery of McGill University, Director of the Department of Neuroscience of McGill University Health Centre, and co-founder of the Tanenbaum Open Science Institute. He was recently elected Vice-President of